Last 38 quarters of trend data · Financial Services · Financial - Credit Services
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -4.13 | — | — | — | — | — | — | — | — | — | — | 2.06 | 2.32 |
| — | — | — | — | — | — | — | — | — | — | — | +1005.5% | — | |
| P/S Ratio | 38.20 | 25.36 | 29.23 | 5.99 | 4.59 | 9.09 | 5.80 | 4.42 | 1.49 | 1.02 | 1.08 | 0.29 | 0.33 |
| — | +179.1% | +404.3% | +35.6% | +207.5% | +789.6% | +435.8% | +1414.3% | +355.3% | -0.7% | +30.6% | -98.9% | -98.2% | |
| P/B Ratio | 2.83 | 2.00 | 2.30 | 0.41 | 0.32 | 0.20 | 0.13 | 1.48 | 0.50 | 0.31 | 0.32 | 0.70 | 0.78 |
| — | +900.6% | +1707.7% | -72.0% | -36.6% | -34.8% | -60.7% | +112.6% | -36.1% | -66.4% | -60.4% | +8.0% | +67.8% | |
| P/FCF | 551.96 | 33.16 | 38.22 | — | — | 12.46 | 7.95 | 16.30 | 5.50 | — | — | — | — |
| — | +166.1% | +380.7% | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Akso Health Group's operating margin was -2113.4% in Q4 2025, down 0.0 pp QoQ and down 1697.6 pp YoY. The trailing four-quarter average of -1060.6% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 210.4% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -1.9% | -6.0% | -6.0% | 2.8% | 2.8% | 5.5% | 5.5% | 4.3% | 4.3% | 10.8% | 10.8% | 9.5% | 9.5% |
| — | -210.4% | -210.4% | -36.0% | -36.0% | -49.3% | -49.3% | -54.2% | -54.2% | -100.0% | -89.2% | +102.0% | -90.5% | |
| Operating Margin | -1125.4% | -2113.4% | -2113.4% | -7.8% | -7.8% | -415.7% | -415.7% | -259.2% | -259.2% | -1060.5% | -1060.5% | -1.9% | -1.9% |
| — | -408.4% | -408.4% | +97.0% | +97.0% | +60.8% | +60.8% | -13857.6% | -13857.6% | -241.5% | -785.5% | +100.0% | +99.9% | |
| Net Margin | -913.4% | -1713.4% | -1713.4% | -8.5% | -8.5% | -394.6% | -394.2% | -342.9% | -342.9% | -1119.5% | -1119.5% | 13.8% | 13.8% |
| — | -334.2% | -334.6% | +97.5% | +97.5% | +64.8% | +64.8% | -2593.2% | -2593.2% | -307.1% | -755.7% | -99.9% | +100.4% |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -80.0% | -33.7% | -33.6% | -0.1% | -0.2% | -2.2% | -4.2% | -28.7% | -21.6% | -83.9% | -79.0% | 8.2% | 7.3% |
| — | -1456.5% | -706.1% | +99.5% | +99.2% | +97.4% | +94.7% | -450.0% | -394.6% | -170.0% | -217.0% | -90.5% | +130.3% | |
| ROA | -75.6% | -31.3% | -31.4% | -0.1% | -0.2% | -2.1% | -3.8% | -9.1% | -8.2% | -36.2% | -35.8% | 3.9% | 1.9% |
| — | -1379.6% | -732.5% | +98.5% | +98.0% | +94.2% | +89.5% | -332.7% | -521.2% | -254.7% | -330.6% | -92.5% | +114.0% | |
| ROIC | -73.9% | -31.0% | -30.6% | -0.1% | -0.1% | -1.7% | -3.2% | -8.3% | -7.2% | -38.5% | -37.0% | -0.6% | -0.5% |
| — | -1725.7% | -842.1% | +98.8% | +98.4% | +95.6% | +91.2% | -1376.4% | -1286.2% | -177.7% | -437.1% | +97.4% | +94.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has weakened 64.1% YoY to 14.20x, tightening the short-term liquidity position. Debt/Equity has declined for 3 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | — | 0.01 | 0.07 | 1.88 | — | 1.10 | — | 0.98 |
| — | — | -27.7% | -63.9% | -98.7% | — | -98.7% | — | +93.0% | — | -63.8% | — | +58.9% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 14.20 | 14.20 | 14.20 | 8.19 | 8.19 | 39.52 | 39.52 | 1.46 | 1.46 | 1.76 | 1.76 | 1.90 | 1.90 |
| — | -64.1% | -64.1% | +460.4% | +460.4% | +2144.4% | +2144.4% | -23.1% | -23.1% | +42.0% | +41.6% | +10.5% | +10.5% | |
| Quick Ratio | 14.20 | 14.20 | 14.20 | 8.19 | 8.19 | 39.52 | 39.52 | 1.46 | 1.46 | 1.76 | 1.76 | 1.90 | 1.90 |
| — | -64.1% | -64.1% | +460.4% | +460.4% | +2144.4% | +2144.4% | -23.1% | -23.1% | +42.0% | +41.6% | +10.5% | +10.5% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 38 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying AHG stock.
Akso Health Group's current P/E is -4.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Akso Health Group's current operating margin is -1125.4%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Akso Health Group's business trajectory between earnings reports.